Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, distinguishing it from approved agents such as semaglutide or tirzepatide
Your provider will review your medication list during your consultation
Beyond Skin: GHK-Cu's Systemic Health Benefits GHK-Cu's influence extends far beyond cosmetic improvements, impacting various systemic health aspects through its gene-modulating and regenerative properties
Testing Protocol: Certificates of Analysis (COAs) are available for each batch to ensure quality standards and for research compliance requirements
US$ 22.00
US$ 20.01
US$ 23.84
US$ 21.50
